These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 2884849)
21. Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. Kenny BA; Miller AM; Williamson IJ; O'Connell J; Chalmers DH; Naylor AM Br J Pharmacol; 1996 Jun; 118(4):871-8. PubMed ID: 8799556 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of human ether-a-go-go-related gene potassium channels by alpha 1-adrenoceptor antagonists prazosin, doxazosin, and terazosin. Thomas D; Wimmer AB; Wu K; Hammerling BC; Ficker EK; Kuryshev YA; Kiehn J; Katus HA; Schoels W; Karle CA Naunyn Schmiedebergs Arch Pharmacol; 2004 May; 369(5):462-72. PubMed ID: 15098086 [TBL] [Abstract][Full Text] [Related]
23. Evidence for existence of postjunctional alpha 1- and alpha 2-adrenoceptors in cat pulmonary vascular bed. Hyman AL; Kadowitz PJ Am J Physiol; 1985 Oct; 249(4 Pt 2):H891-8. PubMed ID: 2864862 [TBL] [Abstract][Full Text] [Related]
24. Sympathetic neurotransmission in the rat testicular capsule: functional characterization and identification of mRNA encoding alpha1-adrenoceptor subtypes. Jurkiewicz NH; Caricati-Neto A; Verde LF; Avellar MC; Reuter HR; Jurkiewicz A Eur J Pharmacol; 2006 Aug; 543(1-3):141-50. PubMed ID: 16822496 [TBL] [Abstract][Full Text] [Related]
25. Antihypertensive drugs interacting with alpha- and beta-adrenoceptors. A review of basic pharmacology. van Zwieten PA Drugs; 1988; 35 Suppl 6():6-19. PubMed ID: 2841084 [TBL] [Abstract][Full Text] [Related]
26. The pharmacology of prazosin, an alpha 1-adrenoceptor antagonist and the basis for its use in the treatment of essential hypertension. Davey MJ Clin Exp Hypertens A; 1982; 4(1-2):47-59. PubMed ID: 6122521 [TBL] [Abstract][Full Text] [Related]
27. Involvement of pertussis toxin-sensitive and -insensitive mechanisms in alpha-adrenoceptor modulation of noradrenaline release from rat sympathetic neurones in tissue culture. Hill CE; Powis DA; Hendry IA Br J Pharmacol; 1993 Sep; 110(1):281-8. PubMed ID: 8106104 [TBL] [Abstract][Full Text] [Related]
28. The alpha 1- and alpha 2-adrenoceptor selectivity of drugs with potential effects on blood pressure--a radioligand-binding study. Offermeier J; van Rooyen JM; Rossouw J S Afr Med J; 1986 Feb; 69(4):234-6. PubMed ID: 2869590 [TBL] [Abstract][Full Text] [Related]
29. The operation of autoregulatory feedback loops in noradrenergic transmission to cardiovascular effector tissues. Rand MJ; Yang C; Cole-Goodwin HM; McCulloch MW; Story DF J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S41-5. PubMed ID: 6175843 [TBL] [Abstract][Full Text] [Related]
30. Comparison of pharmacokinetics and pharmacodynamics of adrenoceptor agonists and antagonists as antihypertensive agents. Louis WJ; McNeil JJ; Anavekar SN; Conway EL; Workman B; Howes LG; Drummer OH; Jarrott B J Cardiovasc Pharmacol; 1987; 10 Suppl 12():S100-3. PubMed ID: 2455158 [TBL] [Abstract][Full Text] [Related]
31. Hemodynamic and neuroendocrine responses to acute and chronic alpha-adrenergic blockade with prazosin and phenoxybenzamine. Mulvihill-Wilson J; Gaffney FA; Pettinger WA; Blomqvist CG; Anderson S; Graham RM Circulation; 1983 Feb; 67(2):383-93. PubMed ID: 6129077 [TBL] [Abstract][Full Text] [Related]
32. New alpha 1-adrenergic receptor antagonists for the treatment of hypertension: role of vascular alpha receptors in the control of peripheral resistance. Cubeddu LX Am Heart J; 1988 Jul; 116(1 Pt 1):133-62. PubMed ID: 2899387 [TBL] [Abstract][Full Text] [Related]
33. Inhibitory effect of calcium antagonist drugs on vasoconstriction induced by vascular alpha 2-adrenoceptor stimulation. van Zwieten PA; Timmermans PB; Thoolen MJ; Wilffert B; De Jonge A Am J Cardiol; 1986 Feb; 57(7):11D-15D. PubMed ID: 2869674 [TBL] [Abstract][Full Text] [Related]
34. Development and trends in the drug treatment of essential hypertension. van Zwieten PA J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322 [TBL] [Abstract][Full Text] [Related]
35. Effects of four different alpha(1)-adrenoceptor antagonists on alpha-adrenoceptor agonist-induced contractions in isolated mouse and hamster ureters. Kobayashi S; Tomiyama Y; Maruyama K; Hoyano Y; Yamazaki Y; Kusama H J Smooth Muscle Res; 2009 Aug; 45(4):187-95. PubMed ID: 19783871 [TBL] [Abstract][Full Text] [Related]
36. Pharmacological analysis of postjunctional alpha-adrenoceptors mediating contractions to (-)-noradrenaline in the rabbit isolated lateral saphenous vein can be explained by interacting responses to simultaneous activation of alpha 1- and alpha 2-adrenoceptors. Daly CJ; McGrath JC; Wilson VG Br J Pharmacol; 1988 Oct; 95(2):485-500. PubMed ID: 2906557 [TBL] [Abstract][Full Text] [Related]
37. Review of the use of alpha-adrenoceptor antagonists in hypertension. Stokes GS; Marwood JF Methods Find Exp Clin Pharmacol; 1984 Apr; 6(4):197-204. PubMed ID: 6146746 [TBL] [Abstract][Full Text] [Related]
38. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856. Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482 [TBL] [Abstract][Full Text] [Related]
39. Apoptotic impact of alpha1-blockers on prostate cancer growth: a myth or an inviting reality? Tahmatzopoulos A; Kyprianou N Prostate; 2004 Apr; 59(1):91-100. PubMed ID: 14991869 [TBL] [Abstract][Full Text] [Related]